Immense Hope in the Fight against Rare Genetic Diseases!

Immense hope in the fight against rare genetic diseases!

Sheba Medical Center (Israel) has launched the very first clinical trial of mitochondrial cell therapy to treat Pearson Syndrome, a rare disease often fatal in children, caused by a deletion of mitochondrial DNA (the “powerhouses” of our cells).

The Principle: This revolutionary therapy involves enriching the patient’s stem cells with healthy mitochondria, often sourced from the mother, to restore vital cellular energy.

The Significance: This is a major breakthrough that could pave the way for treatments for all diseases related to mitochondrial dysfunction.

Discover this medical achievement that redefines the future of cell therapies. 👇

https://www.shebaonline.org/mitochondrial-cell-therapy-trial-for-pearson-syndrome/?fbclid=IwY2xjawN4c9ZleHRuA2FlbQIxMABicmlkETBDMDdQWFlrdWNSV3FCUVpjc3J0YwZhcHBfaWQQMjIyMDM5MTc4ODIwMDg5MgABHokhD0lQMfCYmkhWwf2eIu5Escq2sMBXoAz1zUxfePBr_hBZ5yUEoYDQoLXO_aem_g-GDGkBumu8RruMmcKqVtw

Share on:

Subscribe to the AMMi newsletter

We could not confirm your subscription.
Your subscription to our newsletter is confirmed.

More articles in the same category

Researchers from Inserm and the NeuroCentre Magendie (Bordeaux) published a fascinating study in August 2025: they successfully stimulated mitochondrial activity

Mitochondrial diseases are rare, complex, and often misdiagnosed. This is why MITOMICS, an ambitious French project funded as part of

MEET THE PEOPLE BEHIND Epilepsy Plus – E+ Introducing Emma Del Rey, E+ consultant, Board Member of International Mito Patients,